Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study-Reference-Cited by-同舟云学术

Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study

Published:2014-06-26 Issue:7 Volume:66 Page:980-989
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Yelin Edward¹,Tonner Chris¹,Kim Seoyoung C.²,Katz Jeffrey N.³,Ayanian John Z.⁴,Brookhart M. Alan⁵,Solomon Daniel H.³

Affiliation:

1. University of California; San Francisco

2. Brigham and Women's Hospital and Harvard School of Public Health; Boston Massachusetts

3. Brigham and Women's Hospital; Boston Massachusetts

4. University of Michigan; Ann Arbor

5. University of North Carolina; Chapel Hill

Funder

NIH

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Multidisciplinary Clinical Research Center

Amgen

Agency for Healthcare Research and Quality

National Institute on Aging

Patient-Centered Outcomes Research Institute (funding announcement 12001)

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.22244/fullpdf

Reference24 articles.

1. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis;Saag;Arthritis Rheum,2008

2. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2012

3. Gaps in care for rheumatoid arthritis: a population study;LaCaille;Arthritis Rheum,2005

4. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal;Schmajuk;Arthritis Rheum,2007

5. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans;Schmajuk;JAMA,2011

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viewpoint: how to measure comorbidities in patients with rheumatoid arthritis – clinical and academic value;Rheumatology;2023-10-01

2. Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis;Exploratory Research in Clinical and Social Pharmacy;2023-09

3. Hospitalization, Critical Illness, and Mortality Outcomes of COVID‐19 in Patients With Rheumatoid Arthritis;ACR Open Rheumatology;2023-08-02

4. Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational study;Health Science Reports;2023-03

5. Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis;Arthritis Care & Research;2022-12-28